Market Overview

Zynerba Pharmaceuticals (NASDAQ: ZYNE)

5.57 -0.16 (-2.79%)

Earnings

QuarterPriorEstimateActualSurprise
Q3 2020
Pre-Market
EPS:
REV:
-0.08
0



Q2 2020
Pre-Market
EPS:
REV:
-0.50
0



Q1 2020
Pre-Market
EPS:
REV:
-0.47
0



Q4 2019
Pre-Market
EPS:
REV:
-0.44
86K



Q3 2019
Pre-Market
EPS:
REV:
-0.47

-0.08
0

Q2 2019
Pre-Market
EPS:
REV:
-0.89
0
-0.50
188.47M
-0.50
0
0%
-100%
Q1 2019
Pre-Market
EPS:
REV:
-0.91
0
-0.48
-0.47
0
2.08%
Q4 2018
Pre-Market
EPS:
REV:
-0.60
-0.65
-0.44
86K
-32.31%
Q3 2018
Pre-Market
EPS:
REV:
-0.65
119K
-0.70
-0.47
-32.86%
Q2 2018
Pre-Market
EPS:
REV:
-0.64
-0.78
-0.89
14.1%

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!